December
AEMD) Declares Monetary Outcomes for the Fiscal Third Quarter Ended December 31, 2024 and Offers Company Replace
SAN DIEGO – February 12, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic firm centered on growing merchandise to deal with most cancers and life-threatening infectious illnesses, at present reported monetary outcomes for its fiscal third quarter ended December 31, 2024 and supplied an replace on current developments. Paid Information Dissemination of […]